• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Baxter to pay $18m to settle moldy IV plant case

January 13, 2017 By Brad Perriello

BaxterBaxter (NYSE:BAX) agreed to pay $18 million to settle criminal and civil cases stemming from a North Carolina sterile intravenous solution plant where mold was found in air filters.

The agreement includes penalties and forfeitures of some $16 million and another $2.2 million to settle a civil qui tam lawsuit with the U.S. Justice Dept. Whistleblower Christopher Wall, who filed the False Claims suit, is due to receive about $432,000 from the case, according to the Justice Dept.

Federal prosecutors alleged that manager’s at Baxter’s North Cove plant in Marion, N.C., ignored warnings about mold found in the filters above the clean room where the sterile products were made from July 2011 to November 2012. There was no evidence that the mold contaminated the IV solutions.

Baxter spokeswoman Deborah Spak told Reuters that the North Cove plant’s handling of the mold issue “was not consistent with Baxter’s standards” and resulted in changes at the company.

“We took a number of actions to address these issues, including terminating several members of the facility’s management team and enhancing the training and compliance processes for employees throughout the facility,” Spak said in prepared remarks.

Last October, Baxter recalled filters used to remove bacteria and other microscopic matter from water-based IV solutions, due to the presence of particulate matter and the potential absence of filter layers.

In 2014 the Chicago-area company recalled 2 lots of its peritoneal dialysis solution over concerns that the product may have been contaminated during the manufacturing process.

Filed Under: Hospital Care, Legal News Tagged With: Baxter International

IN CASE YOU MISSED IT

  • Insulet hires new chief HR officer from J&J
  • Breakthrough T1D, Mattel debut Barbie doll with type 1 diabetes
  • Medtronic Diabetes names CFO with consumer experience ahead of separation
  • Diabeloop launches insulin delivery algorithm in Germany
  • GlucoModicum has positive data for needle-free CGM

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS